Stefan K.F. Schwabe
Executive Vice President of Research and Development, Chief Medical Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Supernus Pharmaceuticals, Inc. (SUPN)
Proxy statement
Start not stated–2020-12-31
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Supernus Pharmaceuticals, Inc. (SUPN) | M.D., Ph.D. Executive Vice President of Research and Development, Chief Medical Officer | $413,001 | $1,189,554 |
| 2019 | Supernus Pharmaceuticals, Inc. (SUPN) | M.D., Ph.D. Executive Vice President of Research and Development, Chief Medical Officer | $401,175 | $1,469,056 |
| 2018 | Supernus Pharmaceuticals, Inc. (SUPN) | M.D., Ph.D. Executive Vice President of Research and Development, Chief Medical Officer | $390,000 | $1,279,199 |
| 2017 | Supernus Pharmaceuticals, Inc. (SUPN) | M.D., Ph.D. Executive Vice President of Research and Development, Chief Medical Officer | $378,000 | $1,248,382 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.